Written by Klarity Editorial Team
Published: May 24, 2026

If you’ve been lying awake at 3 AM wondering whether you can get help for your insomnia without leaving home, you’re not alone—and yes, telehealth treatment for insomnia is not only possible but increasingly common in 2025.
Chronic insomnia affects roughly 10-15% of American adults, causing difficulty falling asleep, staying asleep, or waking too early at least three nights per week for three months or longer. The daytime consequences—fatigue, irritability, difficulty concentrating—can significantly impact your quality of life. Fortunately, the expansion of telehealth services has made professional insomnia treatment more accessible than ever before.
This guide will walk you through everything you need to know about getting insomnia treatment via telehealth in 2025, including what medications can be prescribed remotely, which states allow it, what to expect during your virtual visit, and when you should seek in-person care instead.
Yes, telehealth providers can legally prescribe insomnia medications in all 50 states—with some important distinctions based on the type of medication and your state’s specific regulations.
At the federal level, the Ryan Haight Online Pharmacy Consumer Protection Act of 2008 requires an in-person medical evaluation before prescribing controlled substances via the internet. However, this law explicitly applies only to controlled medications (Schedule II-V drugs like Ambien, benzodiazepines, or stimulants)—it does not restrict telehealth prescribing of non-controlled medications.
This is crucial for insomnia treatment because the most commonly prescribed telehealth sleep medications—trazodone and low-dose doxepin (Silenor)—are not classified as controlled substances. This means there are no federal barriers to prescribing these medications via telehealth after an appropriate virtual evaluation.
For controlled substance prescriptions (including certain sleep medications like zolpidem/Ambien), the DEA implemented temporary flexibilities during the COVID-19 pandemic that waived the in-person examination requirement. As of December 2025, these flexibilities have been extended through December 31, 2025, marking the third extension since the public health emergency ended.
This means that even controlled sleep medications can currently be prescribed via telehealth in most states, though these rules are temporary and expected to change in 2026 when the DEA finalizes permanent telemedicine prescribing regulations.
While federal law sets the baseline, each state has its own telehealth regulations. Here’s what you need to know about key states:
California: Allows telehealth exams to satisfy the ‘good faith exam’ requirement for prescribing. No in-person visit required for non-controlled medications. Pending legislation (AB 1503) may further expand access by allowing asynchronous evaluations.
Texas: Permits telemedicine prescribing after a standard-of-care evaluation, typically via video. For chronic pain conditions, two-way audio/video is required unless the patient was seen in person within 90 days. Non-controlled insomnia medications can be prescribed via phone or video consultation.
Florida: Telehealth consultations satisfy examination requirements for prescribing. However, Florida maintains a ban on telemedicine prescribing of Schedule II controlled substances (with exceptions for psychiatric care, inpatient settings, hospice, and nursing home patients).
New York: No in-person requirement for non-controlled medications. In May 2025, New York finalized rules for controlled substance prescribing that mirror proposed federal guidelines, including a 30-day supply limit for new prescriptions without an in-person exam.
New Hampshire: Notably progressive—as of August 2025, Senate Bill 252 eliminated any prior in-person examination requirement for teleprescribing, requiring only appropriate telehealth evaluation and at least annual follow-ups.
Alabama: Requires an in-person evaluation within 12 months if a patient has received only telehealth visits (more than 4 visits) for the same condition over a year. This applies to all conditions, including insomnia management.
The good news? Every state allows telehealth prescribing of non-controlled insomnia medications like trazodone and doxepin, though the specific requirements for establishing a provider-patient relationship vary.
Telehealth providers typically focus on non-controlled sleep medications that are both effective and carry lower abuse potential. Here are the most common options:
DEA Schedule: None (not a controlled substance)
How it works: Originally developed as an antidepressant, trazodone at lower doses (25-100mg) is widely prescribed off-label for insomnia. It works by blocking serotonin receptors and has mild sedating properties.
Telehealth availability: ✅ Fully available in all states via telehealth with no in-person requirement
Typical prescription: Usually started at 25-50mg at bedtime, with the option to increase to 100mg if needed. Providers often prescribe a 30-day initial supply to assess effectiveness and side effects, then provide refills for 90 days or longer with appropriate follow-up.
Common side effects: Morning grogginess, dizziness, dry mouth. Rare but serious: priapism (prolonged erection) in men.
Best for: People with insomnia related to depression or anxiety, those who prefer a non-addictive option, or patients who haven’t responded well to sleep hygiene improvements alone.
DEA Schedule: None (not a controlled substance)
How it works: Doxepin is a tricyclic antidepressant, but at very low doses (3-6mg), it’s FDA-approved specifically for insomnia. It works by blocking histamine receptors, which promotes sleep without the hangover effect of higher doses.
Telehealth availability: ✅ Available in all states via telehealth
Typical prescription: Usually 3-6mg taken 30 minutes before bedtime. Like trazodone, initial prescriptions are often for 2-4 weeks with follow-up, then longer refills with monitoring.
Common side effects: Generally well-tolerated at low doses. Possible morning drowsiness, dry mouth, or constipation.
Contraindications: Not recommended for people with untreated narrow-angle glaucoma or urinary retention.
Best for: People who have trouble staying asleep (sleep maintenance insomnia) rather than falling asleep initially.
Controlled sleep medications like zolpidem (Ambien), eszopiclone (Lunesta), or benzodiazepines (temazepam, etc.) are technically prescribable via telehealth under current COVID-19 flexibilities, but many responsible telehealth platforms avoid these due to:
Most reputable telehealth providers, including Klarity Health, focus on non-controlled options that offer sustainable, safer long-term management without the legal complexity or addiction concerns.
| Medication Type | DEA Schedule | Addiction Risk | Telehealth Prescribing (2025) | Long-term Use |
|---|---|---|---|---|
| Trazodone | None | Low | ✅ Fully permitted, no restrictions | Generally safe for extended use |
| Doxepin (low-dose) | None | Low | ✅ Fully permitted, no restrictions | Safe for chronic insomnia |
| Zolpidem (Ambien) | Schedule IV | Moderate-High | 🟡 Currently allowed under temporary waiver | Not recommended beyond 4 weeks |
| Eszopiclone (Lunesta) | Schedule IV | Moderate-High | 🟡 Currently allowed under temporary waiver | Limited long-term data |
| Benzodiazepines | Schedule IV | High | 🟡 Rarely prescribed via telehealth | Not recommended for insomnia |
Reputable telehealth platforms don’t just hand out prescriptions—they conduct thorough evaluations to ensure medication is appropriate and safe. Here’s what a typical virtual insomnia consultation involves:
Your provider will ask detailed questions about:
Many providers will ask you to keep a sleep diary for 1-2 weeks before or after your initial consultation to better understand your sleep patterns.
Based on your assessment, your provider will develop a personalized treatment plan that typically includes:
Sleep hygiene recommendations: Evidence-based behavioral strategies (consistent sleep schedule, cool dark room, limiting blue light exposure, etc.)
Cognitive Behavioral Therapy for Insomnia (CBT-I): Many telehealth platforms offer or refer to digital CBT-I programs—the gold-standard first-line treatment for chronic insomnia that addresses the thoughts and behaviors perpetuating sleep problems.
Medication (if appropriate): If lifestyle changes and CBT-I haven’t been sufficient, or if you need short-term relief while implementing behavioral strategies, your provider may prescribe a non-controlled sleep medication.
At Klarity Health, our providers take a comprehensive approach to insomnia treatment, ensuring medications are just one component of an evidence-based treatment plan. We focus on sustainable solutions rather than quick fixes, with transparent pricing and the flexibility to accept both insurance and cash pay.
If medication is prescribed:
Responsible telehealth insomnia treatment includes regular monitoring:
Physicians can prescribe any medication within their scope of practice via telehealth in all states, including both controlled and non-controlled insomnia medications.
NP prescribing authority varies significantly by state:
Full Practice Authority States (~27 states including New Hampshire, New York after experience, Alaska, others): NPs can evaluate patients, diagnose conditions, and prescribe medications independently, including via telehealth.
Reduced Practice States (Texas, California transitioning, Florida, Georgia, others): NPs require a collaborative agreement with a physician to prescribe, though they can still provide telehealth services. In these states, a supervising physician reviews cases or co-signs prescriptions according to state protocols.
Restricted Practice States (very few remaining): NPs must work under direct physician supervision.
For non-controlled insomnia medications like trazodone and doxepin, NPs in all states can prescribe these via telehealth as long as they’re practicing within their state’s scope of practice requirements (independently or under appropriate collaboration/supervision).
PAs in all states require a collaborative relationship with a supervising physician, though the degree of oversight varies. PAs can prescribe non-controlled medications in all states and, under appropriate agreements, can manage insomnia via telehealth effectively.
Some states (Texas, Georgia, Alabama, Florida, and others) restrict PA and NP authority to prescribe Schedule II controlled substances, but this doesn’t affect access to first-line telehealth insomnia treatments like trazodone and doxepin.
While telehealth is suitable for many insomnia cases, certain situations require in-person evaluation or specialty care:
Seek immediate in-person medical attention if you experience:
Telehealth providers will refer you for in-person evaluation if they suspect:
Obstructive Sleep Apnea (OSA): Heavy snoring, witnessed breathing pauses, morning headaches, daytime fatigue despite ‘sleeping’ 7-9 hours. OSA requires a sleep study (polysomnography) for diagnosis and may need CPAP therapy rather than insomnia medication.
Restless Legs Syndrome (RLS) or Periodic Limb Movement Disorder: While RLS can often be diagnosed and initially managed via telehealth, severe cases or those not responding to first-line treatments may need in-person neurology consultation.
Narcolepsy: Excessive daytime sleepiness, sudden muscle weakness (cataplexy), sleep paralysis, or hallucinations when falling asleep suggest narcolepsy, which requires specialized sleep medicine evaluation.
Parasomnias: Sleepwalking, night terrors, REM sleep behavior disorder, or other unusual sleep behaviors often need in-person sleep studies for proper diagnosis and safety assessment.
You may need in-person care if you have:
Reputable telehealth providers will recognize when cases exceed telehealth’s appropriate scope and facilitate referrals to in-person specialists rather than attempting to manage complex cases remotely.
Without insurance (cash-pay):
With insurance:
Non-controlled insomnia medications are generally affordable:
Trazodone (generic):
Doxepin/Silenor (generic available):
Klarity Health offers competitive, transparent pricing with the flexibility to accept both insurance and self-pay. Our platform provides access to licensed providers across multiple states, with appointments typically available within 24-48 hours—significantly faster than traditional in-person psychiatry or sleep medicine appointments, which can have wait times of weeks or months.
We believe in sustainable, evidence-based insomnia treatment that addresses root causes, not just symptoms. Our providers are available for ongoing support and medication management, with the convenience of virtual visits that fit into your schedule.
The regulatory landscape for telehealth prescribing is evolving. Here’s what to watch for:
The DEA is expected to publish final regulations for controlled substance prescribing via telemedicine in 2026, after the current temporary flexibilities expire December 31, 2025. Proposed rules have suggested:
Importantly, these changes will not affect non-controlled insomnia medications like trazodone and doxepin, which will remain fully accessible via telehealth.
The trend is toward expanding—not restricting—telehealth access:
Expect to see more integration of:
Can I get sleeping pills prescribed online without a video call?
No, not from legitimate providers. Federal and state laws require an appropriate medical evaluation before prescribing. This typically means at least a live video or phone consultation with a licensed provider. Be wary of websites offering prescriptions based only on questionnaires—these are often operating illegally and may be selling counterfeit or dangerous medications.
How long does a telehealth insomnia appointment take?
Initial consultations typically last 30-45 minutes. Follow-up appointments for medication management are usually 15-20 minutes. Some platforms offer asynchronous messaging for simple questions or prescription refills between scheduled appointments.
Can my regular doctor prescribe insomnia medication via telehealth?
Yes, if they offer telehealth services. Many primary care providers now offer video visits and can prescribe insomnia medications remotely if appropriate. However, if you’re looking for a provider who specializes in sleep issues and mental health, platforms like Klarity Health connect you with providers who have specific expertise in insomnia management.
What happens if the medication doesn’t work?
Your provider will schedule a follow-up (typically 2-4 weeks after starting a new medication) to assess response. If the first medication isn’t effective or causes side effects, they can adjust the dose, try a different medication, or recommend additional interventions like CBT-I. Insomnia treatment often requires some trial and adjustment to find the right approach.
Do I need to see a specialist or can a primary care provider treat my insomnia?
Most uncomplicated insomnia cases can be effectively managed by primary care providers, family medicine doctors, psychiatrists, or specialized nurse practitioners via telehealth. You should seek a sleep medicine specialist (in-person) if you have red flag symptoms suggesting sleep apnea or other sleep disorders, if you’ve tried multiple treatments without success, or if your insomnia is very severe and impacting your safety.
Can I use telehealth for insomnia if I live in a rural area?
Absolutely—that’s one of the greatest benefits of telehealth. You can access experienced providers even if there are no sleep specialists or psychiatrists in your local area. As long as the provider is licensed in your state and you have internet or phone access, you can receive quality insomnia care remotely.
Will my insomnia medication prescription be sent to my local pharmacy?
Yes, prescriptions are sent electronically to the pharmacy of your choice (most states require e-prescribing). You can pick up medications at your local pharmacy or use mail-order pharmacy services if you prefer. The process is the same as with in-person prescriptions.
How often will I need follow-up appointments?
For new medications, expect a follow-up within 2-4 weeks to assess response and side effects. Once you’re stable on a medication, follow-ups are typically every 1-3 months for the first six months, then every 3-6 months for ongoing management. Many states require at least annual comprehensive evaluations for continued prescribing.
If chronic insomnia is affecting your quality of life, you don’t have to continue suffering—and you don’t necessarily need to visit a doctor’s office to get help. Telehealth has made evidence-based insomnia treatment accessible, affordable, and convenient.
Ready to start your journey to better sleep? Klarity Health connects you with experienced, licensed providers who specialize in insomnia and sleep disorders. We offer:
Most patients start feeling improvement within 2-4 weeks of beginning treatment. Don’t let another sleepless night go by—schedule your confidential consultation with Klarity Health today and take the first step toward the restorative sleep you deserve.
U.S. Drug Enforcement Administration. (2024, November 15). DEA and HHS extend telemedicine flexibilities through 2025. https://www.dea.gov/documents/2024/2024-11/2024-11-15/dea-and-hhs-extend-telemedicine-flexibilities-through-2025
Sheppard Mullin. (2025, August 15). Telehealth and in-person visits: Tracking federal and state updates on pandemic-era rules. National Law Review. https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era
Center for Connected Health Policy. (2025). State telehealth laws & reimbursement policies: Online prescribing. https://www.cchpca.org/topic/online-prescribing/
Healthcare Finance News. (2024, November 18). Telehealth prescribing of controlled drugs extended through 2025. https://www.healthcarefinancenews.com/news/telehealth-prescribing-controlled-drugs-extended-through-2025
Texas Board of Nursing. (2025). Advanced practice registered nurse frequently asked questions. https://www.bon.texas.gov/faqpracticeaprn.asp.html
Find the right provider for your needs — select your state to find expert care near you.